Psoriasis,SKYRIZI is indicated for the treatment of moderate to severe plaquepsoriasis in adults (18 years or older) who are candidates for phototherapy or systemic therapy.,Psoriatic Arthritis,SKYRIZI is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to or are intolerant to one or more disease-modifying anti-rheumatic drugs (DMARDs).
SKYRIZI may be used with or without conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs).
How to take it
The way to take this medicine is: Subcutaneous.
This medicine is injected, usually with a short needle or pen-like device, into the fat just beneath the skin.
Store at 2 to 8 degrees Celsius
Protect from Light
Do not Freeze
Refrigerate
Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Solution is colourless to slightly yellow and clear to slightly opalescent. May contain a few translucent to white product-related particles
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on March 1, 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
Psoriasis,SKYRIZI is indicated for the treatment of moderate to severe plaquepsoriasis in adults (18 years or older) who are candidates for phototherapy or systemic therapy.,Psoriatic Arthritis,SKYRIZI is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to or are intolerant to one or more disease-modifying anti-rheumatic drugs (DMARDs).
SKYRIZI may be used with or without conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs).
How to take it
The way to take this medicine is: Subcutaneous.
This medicine is injected, usually with a short needle or pen-like device, into the fat just beneath the skin.
Store at 2 to 8 degrees Celsius
Do not Freeze
Refrigerate
Protect from Light
Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Solution is colourless to yellow and clear to slightly opalescent. Solution may contain a few translucent to white product-related particles
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
Psoriasis,SKYRIZI is indicated for the treatment of moderate to severe plaquepsoriasis in adults (18 years or older) who are candidates for phototherapy or systemic therapy.,Psoriatic Arthritis,SKYRIZI is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to or are intolerant to one or more disease-modifying anti-rheumatic drugs (DMARDs).
SKYRIZI may be used with or without conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs).
How to take it
The way to take this medicine is: Subcutaneous.
This medicine is injected, usually with a short needle or pen-like device, into the fat just beneath the skin.
Store at 2 to 8 degrees Celsius
Do not Freeze
Refrigerate
Protect from Light
Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Solution is colourless to yellow and clear to slightly opalescent. Solution may contain a few translucent to white product-related particles
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
Crohns Disease,SKYRIZI is indicated for the treatment of moderate to severe Crohns disease in adult patients, who have an inadequate response, a lost response, an intolerance or a contra-indication to either conventional or biologic therapy.
How to take it
The way to take this medicine is: Intravenous Infusion.
Store at 2 to 8 degrees Celsius
Do not Freeze
Protect from Light
Refrigerate
Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
600 mg/10 mL Vial: The solution is colourless to slightly yellow and clear to slightly opalescent. The solution may contain a few translucent to white product-related particles.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
Crohns Disease,SKYRIZI is indicated for the treatment of moderate to severe Crohns disease in adult patients, who have an inadequate response, a lost response, an intolerance or a contra-indication to either conventional or biologic therapy.
How to take it
The way to take this medicine is: Subcutaneous.
This medicine is injected, usually with a short needle or pen-like device, into the fat just beneath the skin.
Store at 2 to 8 degrees Celsius
Do not Freeze
Protect from Light
Refrigerate
Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
360 mg/2.4 mL pre-filled cartridge: The solution is colourless to yellow and clear to slightly opalescent. The solution may contain a few translucent to white product-related particles.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.